ReviewFrontiers in pharmacology2023

Engineered biomaterial delivery strategies are used to reduce cardiotoxicity in osteosarcoma.

Yulin Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.